Allergan to buy experimental psoriasis drugmaker Vitae for $639 mln
 

Allergan to buy experimental psoriasis drugmaker Vitae for $639 mln
NEW YORK, Sept 14 (Reuters) - Allergan Inc onWednesday said it would buy Vitae Pharmaceuticals,which is testing an experimental drug to treat psoriasis andother autoimmune disorders, for $639...http://feeds.feedburner.com/~ff/reut...?d=yIl2AUoC8zA http://feeds.feedburner.com/~ff/reut...rI:F7zBnMyn0Lo http://feeds.feedburner.com/~ff/reut...rI:V_sGLiPBpWU
http://feeds.feedburner.com/~r/reute...~4/fkdwGQlTKao